Toxicity and efficacy of alemtuzumab combined with CHOP for aggressive T-cell lymphoma: a phase 1 dose-escalation trial. Issue 9 (29th July 2019) - Phillips, Elizabeth H.; Devereux, Stephen; Radford, John; Mir, Naheed; Adedayo, Toyin; Clifton-Hadley, Laura; Johnson, Rod